NK

NuVasive IncMUN NuVasive Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

2.085

Small

Exchange

XMUN - Boerse Muenchen

NK8.MU Stock Analysis

NK

Uncovered

NuVasive Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

31/100

Low score

Market cap $B

2.085

Dividend yield

Shares outstanding

52.192 B

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. The company is headquartered in San Diego, California and currently employs 3,000 full-time employees. The company went IPO on 2004-05-13. The firm is focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company offers a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for the spine and specialized orthopedic procedures. The company also designs and sell expandable growing rod implant systems for the treatment of early-onset scoliosis that can be non-invasively lengthened after implantation with incremental adjustments via an external remote controller using magnetic technology called MAGneticExternal Control (MAGEC). The company operates in more than 50 countries serving surgeons, hospitals, and patients.

View Section: Eyestock Rating